Assisted Reproductive Technology Market Size, Share, and Trends 2024 to 2034

Assisted Reproductive Technology Market Size and Forecast 2024 to 2034

The global assisted reproductive technology market size is accounted for USD 31.61 billion in 2024 and is anticipated to reach around USD 80.51 billion by 2034, growing at a CAGR of 9.80% from 2024 to 2034.

Assisted Reproductive Technology Market Key Takeaways

• Europe region dominated the market in 2023 with 38% of the revenue share.
• By product, the accessory & disposable segment accounted for 51% of revenue share in 2023.
• By end-uses, the fertility clinics & other facilities segment has captured 79.9% of the overall revenue share in 2023. 
• By type, the IVF segment has accounted for the highest revenue share of around 93.5% in 2023.

Europe Assisted Reproductive Technology Market Size and Growth 2024 to 2034

The Europe assisted reproductive technology market size is evaluated at USD 12.01 billion in 2024 and is predicted to be worth around USD 31 billion by 2034, rising at a CAGR of 9.93% from 2024 to 2034.

On the basis of geography in segmentation of the assisted reproductive technology, the Asia Pacific region dominates the market of assisted reproductive technology with increased developments and increase in research and development with enhanced investment from the government with increased technologies and infrastructure in the health care sectors. Increasing disposable with enhanced utilization of the health care center due to infertility problems rising among women.

Europe also with significant growth in assisted reproductive technology with increasing interest from the market players in developing technologies for treating infertility. North America, the Middle East, and Africa in the process to contribute for increasing the growth rate of assisted reproductive technology during the forecast period.

Market Overview

Assisted reproductive technology is carried out in medical centers. With the increased growth of infertility and enhance assisted reproductive technology. Assisted reproductive technology is fertility treatment. Which involved medical treatment, for example, in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, or fertility treatment including medications for gaining fertility. Assisted reproductive technology is majorly involved in reproductive endocrinology and infertility. 

Assisted reproductive technology is also involved in surrogacy treatment but cannot be used in every surrogacy treatment. Infertility issues can be solved using assisted reproductive technology with the conventional method of treating infertility with enhanced sterility. The advanced technologies developed in the market for treating infertility problems with increasing research and development help to grow the market of assisted reproductive technology with an enhanced growth rate during the forecast period.

Impact of Covid-19 on assisted reproductive technology with a negative effect on the market with reduced patients visiting the health care centres at a reduced market rate due to fewer demands. Post-pandemic impact of covid-19 on the assisted reproductive technology market with enhanced growth rate and enhanced consultation and treatment involved in infertility helps to boost the market of assisted reproductive technology.

Assisted Reproductive Technology Market Growth Factors

Enhance the growth of assisted reproductive technology with increasing rates of infertility rate due to Sexually Transmitted Infections, increased smoking, increasing obesity, endometriosis, Polycystic Ovary Syndrome, Primary Ovary Insufficiency, and others. With the increase in demands from the customer to gain fertility from various technology developed and to drive the market of assisted reproductive technology.

The rise in acceptance of the developed technology by the market enhances the efficiency of the treatment or medication involved in treating infertility problems. Developed technologies such as Preimplantation Genetic Testing, Magnetic Activates Cell Sorting, and many more. Increasing awareness regarding the advance developed technology in infertility treatment help to propel the market of assisted reproductive technology with an enhanced growth rate during the forecast period.

The number of an organization participating in an increased number of treatments involved for treating infertility may help to boost the market of assisted reproductive technology. Government support for increasing the advanced technologies in assisted reproductive technology with increased integration of the technologies in the health care sector with enhanced developed technology help to grow the market of assisted reproductive technology. Increased government investment from various regions helps to grow the market with increased revenue share.

Market Scope

Market Dynamics

Key Market Drivers

• Increasing obesity of the women - Increase utilization of assisted reproductive technology from women with increasing infertility due to various regions such as rising obesity, and lack of exercise, which led to increasing obesity among the women which led to several chronic disorders. Which gave rise to increased infertility and enhance the market of assisted reproductive technology with an enhanced market growth rate during the forecast period with enhanced developed technologies in assisted reproductive technology.
• Ovulation disorders - Increasing ovulation disorders among women with enhanced menstruation problems, and hormonal imbalance in the women may affect menstruation and ovulation with increased infertility among the women and helps to drive the market of assisted reproductive technology with increasing demands from the customer and increased integration of newly developed technologies in the healthcare center and enhance the market during the forecast period.
• Dietary intake - Changing lifestyle among the population with increasing chronic disorders and enhancing the number of patients visiting hospitals due to various disorders rising and changing dietary foods with increasing intake of junk foods and increasing obesity led to infertility problems among the women led to increasing in the adoption of assisted reproductive technology with increased advancement help to grow the market.

Key Market Challenges

The increased cost of assisted reproductive technology

• The advanced developed technologies in infertility treatment with increasing problems among women. Enhance the cost of the developed techniques with increased efficiency of the technology, efficacy, accuracy, and precision of the treatment. led to reducing the market of assisted reproductive technology due to fewer demands from the customer and a decline in the market of assisted reproductive technology.

Lack of skill among the people

• The introduction of the advanced treatment involved in assisted reproductive technology for treating infertility with the increased number of techniques for performing the procedure in fertility technology with an enhanced number of procedures involves upgraded skills required for carrying out the procedure. Lack of skill among the people may hamper the market of assisted reproductive technology due to lack of knowledge among the workers may challenge the market growth rate during the forecast period.

The increasing availability of options

• The various number of options developed in assisted reproductive technology with an increased number of treatments available for treating infertility may reduce the market of assisted reproductive technology due to the numerous options available in the medical center may challenge the market of assisted reproductive technology to grow to a larger extend.

Key Market Opportunities

Emerging regions with enhanced development

• The wide acceptance of the advance developed technology across various regions with the increasing number of facilities in the health care centers with improved infrastructure in the health care centers for enhancing the treatment of improving fertility with enhanced technology drives the market of assisted reproductive technology with enhancing demands from the market due to increasing number of women with infertility help to boost the market of assisted reproductive technology.

Increased support from the government

• Governments from various regions and countries with increased support for increasing the technologies in assisted reproductive technology for treating fertility problems and enhancing the research for increasing the number of treatments with improved efficiency and increasing the fertility rate among women with the utilization of new technology developed. Increased funding from the government with development and technology integration in medical centers and imposition of policies such as reimbursement help to grow the market rate during the forecast period.

Product Insights

On the basis of product segmentation of assisted reproductive technology, the accessory & disposable market with largest market share with increasing demands from the medical center for the developed technologies in infertility problems. Increasing infertility prevalence among women and enhanced demands for fertilization techniques developed.

Increasing the number of screening of the sperms, analysis, and gametes handling techniques with an increasing number of treatments and enhancing the technologies with new techniques and help to drive the market of assisted reproductive technology. Reagents and media also with significant growth of the technology with enhanced demands for embryo transfer and increasing In Vitro Fertilization and enhance the market growth.

Technology Insights

On the basis of technology in segmentation of the assisted reproductive technology, In - Vitro Fertilization accounts for the largest market growth in assisted reproductive technology. This helps to enhance the market rate with increasing demands from the medical sector for new technologies with increasing efficiency of the treatment and solving the infertility problem and enhance the fertility rate among the women with various medications and treatments developed in the assisted reproductive technology.

Moreover, artificial insemination also with the highest market growth with increasing CAGR and improving infrastructure may extend the market to a larger extent during the forecast period.

End-User Insights

On the basis of end-user in segmentation of the assisted reproductive technology, the fertility clinic segment account for the fastest growing segment with the increasing prevalence of infertility disorder among women due to changing lifestyle, changing dietary intake, increased obesity, lack of exercise may be led to increase infertility and enhance demands for the treatment and medications for increasing the fertility with increasing the efficiency of the treatment.

The surgical center also growing with increasing demands and growing the market growth rate of assisted reproductive technology to a larger extent during the forecast period.

Key Market Players Insights

The key market players involved in the introduction of the newly developed technology in assisted reproductive technology with increasing efficiency of the treatment help to rise the market with increasing demands from patients with enhanced infertility. A large number of investments done by the key market players for introducing new technology and constant research and development in assisted reproductive technology. Which accelerates the market of assisted reproductive technology with a rising rate during the forecast period.

Assisted Reproductive Technology Market Companies

• Vitrolife AB
• Thermo Fisher Scientific, Inc
• The Cooper Companies, Inc (Cooper Surgical Inc.)
• Progyny Inc.
• Oxford Gene Technology
• Millendo Therapeutics, Inc
• Merck KGaA (EMD Serono, Inc)
• Genera Biomedx
• Fujifilm Holdings Corporation (Irvine Scientific Sales Company)
• Cook Medical Inc
• Ferring B.V.
• Bloom IVF Centre
• European Sperm Bank
• Microm U.K. Ltd
• Cosmos Biomedical Ltd
• Cryolab Ltd

Recent Developments

• In the year 2021, Cooper Surgical introduced a collaboration with Virtus Health and enhance the developed technologies in fertility and increasing research and development and making the availability of treatment for infertile couples.
• In the year 2021, Hamilton Thorne Ltd. developed GYNEMED GM501, which is utilized for in-vitro washing and techniques mentioned for the handling of oocytes and embryos by humans and got approval from the United States and Europe and is ready for marketing.

Segments Covered in the Report

By Product

• Instrument
  • Laser systems
  • Micromanipulator
  • Cabinet
  • Ovum aspiration pump
  • Imaging systems
  • Incubator
  • Cryosystem
  • Sperm separation system
  • Others
• Accessory & Disposable 
• Reagents & media
  • Embryo culture media
  • Ovum processing media
  • Semen processing media
  • Cryopreservation media

By Technology

• In-Vitro Fertilization (IVF)
  • Fresh Donor
  • Frozen Donor
  • Fresh Non-Donor
  • Frozen Non-Donor
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination

By Diagnosis

• Ovulation Testing
• Hysterosalpingography

By End-User 

• Ambulatory surgical centers
• Hospitals
• Clinics
• Diagnostic centers
• Gynecology Centers
• Feminist Health Centers
• IVF Centers

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)